Physician profile
Chad Howze
NPI 1295112738
$11,134.85
in general payments reported to CMS, 2019-2025
32 companies · $3,929 in 2025
The $3,929 reported for 2025 was more than what 91% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $86.53 · 2021: $2,069 · 2022: $1,836 · 2023: $2,611 · 2024: $486 · 2025: $3,929.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,911 · Travel and Lodging: $3,115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,911.10 |
| Travel and Lodging | $3,115.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,556.61 | 2021-2025 | Citrefix, Augment Injectable, Valor |
| Treace Medical Concepts, INC. | $2,498.31 | 2022-2025 | |
| Medinc of Texas | $1,279.85 | 2022-2023 | |
| Orthofix Medical, INC. | $1,045.99 | 2023-2025 | Truelok, Physio-Stim |
| Smith+Nephew, INC. | $276.30 | 2019-2025 | Stravix Pl, Grafix Pl, Collagenase Santyl |
| Paratek Pharmaceuticals, INC. | $251.30 | 2021-2025 | Nuzyra |
| Janssen Pharmaceuticals, INC | $244.03 | 2021 | |
| Horizon Therapeutics Plc | $86.79 | 2019-2022 | |
| Kerecis Limited | $86.26 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Organogenesis INC. | $82.75 | 2023-2024 | Puraply |
| Triad Life Sciences INC. | $76.35 | 2022 | |
| Mission Medical Distribution, LLC | $65.07 | 2023-2024 | |
| Bioventus LLC | $59.17 | 2021-2023 | Exogen Ultrasound Bone Healing System |
| Convatec INC. | $57.78 | 2024 | |
| Acumed LLC | $55.00 | 2024 | Osteomed |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries Lp | $51.18 | 2023-2024 | |
| Nvision Biomedical Technologies, INC. | $51.05 | 2023 | Foot and Ankle |
| Baudax Bio INC. | $45.15 | 2020 | |
| Globus Medical, INC. | $30.62 | 2025 | Senza |
| Axogen | $28.25 | 2019 | |
| Merck Sharp & Dohme LLC | $23.87 | 2019 | |
| Heron Therapeutics, INC. | $23.46 | 2025 | Zynrelef |
| Atland Pharmaceuticals, LLC | $23.33 | 2025 | Tolmetin Sodium, Orphenadrine Citrate, Aspirin and Caffeine |
| Melinta Therapeutics, LLC | $23.29 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $20.00 | 2022 | |
| Depuy Synthes Sales INC. | $19.17 | 2021 | |
| Anika Therapeutics, INC. | $16.89 | 2024 | X-Twist, Tactoset, Integrity |
| Nabriva Therapeutics, Plc | $16.45 | 2020 | |
| Arthrosurface Incorporated | $14.35 | 2025 | Toe Motiontm |
| Arteriocyte Medical Systems, INC. | $13.43 | 2024 | Magellan |
| Abbott Laboratories | $12.80 | 2023 | Proclaim |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Howze listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.